Publisher
Springer Science and Business Media LLC
Reference15 articles.
1. Arber, D. A. et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127, 2391–2405 (2016).
2. Tefferi, A. & Barbui, T. CME Information: polycythemia vera and essential thrombocythemia: 2015 update on diagnosis, risk-stratification, and management. Am. J. Hematol. 90, 163–173 (2015).
3. Elliott, M. A. & Tefferi, A. Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia. Br. J. Hematol. 128, 275–290 (2005).
4. Marchioli, R. et al. Vascular and neoplastic risk in a large cohort of patients with polycythemia vera. J. Clin. Oncol. 23, 2224–2232 (2005).
5. Barbui, T. et al. In contemporary patients with polycythemia vera, rates of thrombosis and risk factors delineate a new clinical epidemiology. Blood 124, 3021–3023 (2014).
Cited by
106 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献